TINA BHUTANI, MD
Dermatology at Spruce St, San Francisco, CA

License number
California A108915
Category
Osteopathic Medicine
Type
Dermatology
Address
Address
515 Spruce St, San Francisco, CA 94118
Phone
(415) 476-4701
(415) 353-7800

Personal information

See more information about TINA BHUTANI at radaris.com
Name
Address
Phone
Tina Bhutani
2290 Francisco St APT 103, San Francisco, CA 94123
Tina Bhutani
San Francisco, CA
(415) 563-5512
Tina Bhutani
10050 Torrey Pines Rd, La Jolla, CA 92093
Tina Bhutani
2290 Francisco St, San Francisco, CA 94123
Tina Bhutani
4000 Gilman Dr, La Jolla, CA 92092

Organization information

See more information about TINA BHUTANI at bizstanding.com

Tina Bhutani MD

515 Spruce St, San Francisco, CA 94118

Industry:
Dermatologist
Phone:
(415) 476-4701 (Phone)
Tina Bhutani

Professional information

Tina Bhutani Photo 1

Dr. Tina Bhutani, San Francisco CA - MD (Doctor of Medicine)

Specialties:
Dermatology
Address:
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
515 Spruce St, San Francisco 94118
(415) 353-7070 (Phone), (415) 502-4126 (Fax)
Languages:
English
Education:
Medical School
University of Southern California / Keck School of Medicine
Graduated: 2008


Tina Bhutani Photo 2

Tina Bhutani, San Francisco CA

Specialties:
Dermatologist
Address:
515 Spruce St, San Francisco, CA 94118
3130 20Th Street, San Francisco, CA 94143


Tina Bhutani Photo 3

Methods Of Treating Diseased Tissue

US Patent:
2012010, May 3, 2012
Filed:
Oct 26, 2011
Appl. No.:
13/282284
Inventors:
John Koo - San Francisco CA, US
Tina Bhutani - San Francisco CA, US
International Classification:
A61M 37/00
US Classification:
604 20
Abstract:
Two or three external therapeutic options such as clobetasol propionate spray, calcitriol ointment, and excimer laser phototherapy are used to treat generalized psoriasis with systemic safety and better efficacy than any systemic or biologic agent. Combinations of these agents, for example used in parallel and/or series for specific durations, can achieve a significant result: a PASI 75 response after only four weeks and/or a PASI 95-100 response after only six weeks.